A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

No Carolina / New York

Professor Eddy Fan Joins Inspira Technologies Scientific Advisory Board

Expert in Critical Care Medicine and Extracorporeal Support

What To Know

  • Professor Eddy Fan is an associate professor in the Interdepartmental Division of Critical Care Medicine and the Institute of Health Policy, Management and Evaluation at the University of Toronto and a staff intensivist at the University Health Network/Mount Sinai Hospital.
  • These include investigations of the epidemiology and use of mechanical ventilation and extracorporeal life support in patients with ARDS, as well as on the development of ICU-acquired weakness, early rehabilitation in ICU patients, and long-term outcomes in survivors of critical illness.

Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) (the “Company” or “Inspira Technologies”), a groundbreaking respiratory support technology company, announced today that Proffesor Eddy Fan, an expert in critical care and extracorporeal life support methods, has joined Inspira Technologies’ Scientific Advisory Board.

Professor Eddy Fan is an associate professor in the Interdepartmental Division of Critical Care Medicine and the Institute of Health Policy, Management and Evaluation at the University of Toronto and a staff intensivist at the University Health Network/Mount Sinai Hospital. Prof. Fan currently holds the medical director of the extracorporeal life support program at the Toronto General Hospital.
Prof. Eddy Fan, commented: “It is exciting to work with Inspira Technologies to design and develop novel extracorporeal support devices that will hopefully provide an additional tool for clinicians treating patients with acute respiratory failure and acute respiratory distress syndrome (ARDS).”
Dr. Fan received an undergraduate degree from the University of Toronto, his medical degree from the University of Western Ontario, and a doctorate in clinical investigation from Johns Hopkins University.
Prof. Fan’s area of academic focus is acute respiratory distress syndrome (ARDS), mechanical ventilation, and extracorporeal support. His research has focused on advanced life support for acute respiratory failure and patient outcomes after critical illness. These include investigations of the epidemiology and use of mechanical ventilation and extracorporeal life support in patients with ARDS, as well as on the development of ICU-acquired weakness, early rehabilitation in ICU patients, and long-term outcomes in survivors of critical illness.
Among his most significant publications:
  • An Official American Thoracic Society/European Society of Intensive Care Medicine/Society of Critical Care Medicine Clinical Practice Guideline: Mechanical Ventilation in Adult Patients with Acute Respiratory Distress Syndrome.” Intensive Care Medicine”
  • Veno-venous extracorporeal membrane oxygenation for acute respiratory failure: a clinical review from an international group of experts.” JAMA”
  • Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries.
Dagi Ben-Noon, Inspira Technologies’ Chief Executive Officer, stated: “We are honored to have Professor Fan on Inspira Technologies’ Scientific Advisory Board. Professor Fan is a distinguished researcher, and his scientific expertise will be of great significance to Inspira Technologies in the development and potential deployment of its ART device.”

Other Executives In the News

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Executives on the Move

“Adding Michael to the Avation leadership team is our next step in launching Vivally,” said Jill Schiaparelli, founder and CEO of Avation Medical. “Patients have been crystal clear that they want a surgical-free, non-invasive treatment option for their OAB symptoms. Our focus now is to ensure that Vivally is easily accessible to the 46 million patients suffering from OAB in this country.”
Dennis has an extraordinary depth of knowledge and is highly respected in the obesity field; I could not imagine anyone more perfect to lead our company,” said Jeff Arnold, Chairman and a Director at Xeno Biosciences since 2017.
Peter Eckes offers more than a 30-year career in the agricultural industry, and provides a unique appreciation for what it takes to bring innovation to the modern agriculture marketplace at scale without losing sight of farmer and consumer needs.

By using this website you agree to accept Medical Device News Magazine Privacy Policy